Wolters Kluwer (OTC:WTKWY) Stock, Quote.Headers.trade-ideas

Wolters Kluwer

Wolters Kluwer is a global provider of professional information, software solutions, and services in health; tax and accounting; environmental, social, and governance; finance; compliance; and legal. More than 60% of revenue is generated in North America and around 30% is from Europe.

Short Ideas

Trading Ideas

WTKWY

On Thursday, shares of Wolters Kluwer (OTC: WTKWY) experienced volatile short activity. After the activity, the stock price went down -0.08% to $111.34.

The overall sentiment for WTKWY has been Bullish.

Short Volatility Alert: Wolters Kluwer

ASHTY

ENGGY

ESLOY

KRYAY

LRLCY

Nestle Sponsored representing Registered Shares Series B

NSRGY

RHHBY

CLPBY

In general, Dividend Aristocrats are the foundation for the portfolios of most serious dividend growth investors. European Dividend aristocrats are typically blue chip stocks that have proven to reward shareholders with rising dividends over a long period.

15 European Dividend Aristocrats To Diversify Your Portfolio

News

Intraday Update

Markets

Movers

AAXN

ABLZF

ACDSF

ACLS

ACRE

ADBE

ADCOF

ADNT

ADSK

ADYEY

AGNC

AIQUY

ALEC

ALFVY

ALLE

AMED

AMRC

AMZN

ANSS

APAM

APPF

ARES

ASML

ASPU

BCPC

BESIY

BFAM

BFST

BKOR

BMRMF

BROG

BTAI

BTDPY

BXMT

CBSH

CCLAY

CCOEY

CCXI

CDAY

CERN

CGEN

CHDN

CIFAF

CLPBF

CNSWF

CPRT

CSGP

CTAS

DDOG

DOCU

DOOO

DPDW

DSGX

ENAKF

ENBP

ENPH

EPAM

Eaton Vance Tax-Advantaged Global Dividend

Stocks That Hit 52-Week Highs On Wednesday

WOLTERS KLUWER S/ADR by Wolters Kluwer N.V.

Wolters Kluwer NV

On Thursday, shares of Wolters Kluwer (OTC: <a class="ticker" href="https://www.benzinga.com/stock/wtkwy#OTC">WTKWY</a>) experienced volatile short activity. After the activity, the stock price went down -0.08% to $111.34.
The overall sentiment for WTKWY has been Bullish.
The signal from the volatility alert is trending Bearish. Therefore, the recommendation is to Increase Short Exposure.
The volatility alert was produced on the prior trading date, 2/16/2023 with a volatility change of +297.8%. The current volatility indicator stands at 18.045.
Overview: 
The securities lending volatility indicator is produced by Tidal Markets, in partnership with Benzinga Insights. Securities lending primarily serves the purpose of providing liquidity to short sellers. When unusual activity occurs in the securities lending markets, it acts as an upstream indicator to what is likely to occur downstream in the regular stock market.
Understanding the Volatility Alert: 
Overall sentiment is considered &quot;bear&quot; when broad market activity of the stock has been shown to indicate a negative directional basis, or is considered &quot;bull&quot; when indicating a positive directional basis. The securities lending volatility indicator provides a signal when it detects unusual short activity. Unusual short activity is based off a computer generated algorithmic formula utilizing securities lending trade details such as the volume of shares being shorted, the rate being paid to short the shares, and the type of collateral being posted - amongst other variables. The current volatility is the respective trading day&#39;s calculated securities lending volatility value. The volatility percentage change is the percentage difference in volatility between the two most recent days. The recommendation is a suggestive strategy, inferred from the strength of the Signal Trending, Current Volatility, and Volatility % Change. Recommendations may include, &quot;Strong Buy&quot;, &quot;Strong Sell&quot;, &quot;Increase Short Exposure&quot;, &quot;Decrease Short Exposure&quot;, or &quot;Market Neutral&quot;.
ANY INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR IMPLY INVESTMENT ADVICE

Long Ideas

Global

General

&nbsp;
<h2>Upgrades</h2>
<ul>
<li>Loop Capital upgraded the previous rating for Albemarle Corp (NYSE:<a class="ticker" href="/stock/ALB#NYSE">ALB</a>) from Hold to Buy. In the fourth quarter, Albemarle showed an EPS of $1.17, compared to $1.73 from the year-ago quarter. At the moment, the stock has a 52-week-high of $188.35 and a 52-week-low of $48.89. Albemarle closed at $157.34 at the end of the last trading period.</li>
<li>According to Barclays, the prior rating for ManpowerGroup Inc (NYSE:<a class="ticker" href="/stock/MAN#NYSE">MAN</a>) was changed from Underweight to Overweight. ManpowerGroup earned $1.48 in the fourth quarter, compared to $2.33 in the year-ago quarter. At the moment, the stock has a 52-week-high of $99.36 and a 52-week-low of $49.57. ManpowerGroup closed at $94.41 at the end of the last trading period.</li>
<li>For Life Storage Inc (NYSE:<a class="ticker" href="/stock/LSI#NYSE">LSI</a>), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. Life Storage earned $1.07 in the fourth quarter, compared to $0.96 in the year-ago quarter. The stock has a 52-week-high of $125.76 and a 52-week-low of $67.31. At the end of the last trading period, Life Storage closed at $83.93.</li>
<li>Compass Point upgraded the previous rating for RLJ Lodging Trust (NYSE:<a class="ticker" href="/stock/RLJ#NYSE">RLJ</a>) from Neutral to Buy. In the fourth quarter, RLJ Lodging showed an EPS of $0.57, compared to $0.41 from the year-ago quarter. At the moment, the stock has a 52-week-high of $16.17 and a 52-week-low of $3.88. RLJ Lodging closed at $15.74 at the end of the last trading period.</li>
<li>According to Compass Point, the prior rating for Park Hotels &amp; Resorts Inc (NYSE:<a class="ticker" href="/stock/PK#NYSE">PK</a>) was changed from Neutral to Buy. In the fourth quarter, Park Hotels &amp; Resorts showed an EPS of $0.53, compared to $0.72 from the year-ago quarter. The stock has a 52-week-high of $23.11 and a 52-week-low of $3.99. At the end of the last trading period, Park Hotels &amp; Resorts closed at $21.75.</li>
<li>For SailPoint Technologies Holdings Inc (NYSE:<a class="ticker" href="/stock/SAIL#NYSE">SAIL</a>), Needham upgraded the previous rating of Hold to Buy. SailPoint Technologies earned $0.10 in the fourth quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $64.19 and a 52-week-low of $11.61. SailPoint Technologies closed at $56.40 at the end of the last trading period.</li>
<li>Morgan Stanley upgraded the previous rating for Spirit AeroSystems Holdings Inc (NYSE:<a class="ticker" href="/stock/SPR#NYSE">SPR</a>) from Equal-Weight to Overweight. For the fourth quarter, Spirit AeroSystems Hldgs had an EPS of $1.31, compared to year-ago quarter EPS of $0.79. The current stock performance of Spirit AeroSystems Hldgs shows a 52-week-high of $61.27 and a 52-week-low of $13.69. Moreover, at the end of the last trading period, the closing price was at $42.87.</li>
<li>For Yandex NV (NASDAQ:<a class="ticker" href="/stock/YNDX#NASDAQ">YNDX</a>), Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. For the fourth quarter, Yandex had an EPS of $0.23, compared to year-ago quarter EPS of $0.26. The stock has a 52-week-high of $74.32 and a 52-week-low of $27.93. At the end of the last trading period, Yandex closed at $63.98.</li>
<li>Wells Fargo upgraded the previous rating for Bain Capital Specialty Finance Inc (NYSE:<a class="ticker" href="/stock/BCSF#NYSE">BCSF</a>) from Underweight to Equal-Weight. Bain Capital Specialty earned $0.34 in the fourth quarter, compared to $0.41 in the year-ago quarter. At the moment, the stock has a 52-week-high of $19.76 and a 52-week-low of $7.11. Bain Capital Specialty closed at $14.05 at the end of the last trading period.</li>
<li>According to JP Morgan, the prior rating for Plug Power Inc (NASDAQ:<a class="ticker" href="/stock/PLUG#NASDAQ">PLUG</a>) was changed from Neutral to Overweight. Plug Power earned $0.05 in the fourth quarter, compared to $0.06 in the year-ago quarter. The current stock performance of Plug Power shows a 52-week-high of $75.49 and a 52-week-low of $2.53. Moreover, at the end of the last trading period, the closing price was at $48.38.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>
&nbsp;
<h2>Downgrades</h2>
<ul>
<li>According to Barclays, the prior rating for Kodiak Sciences Inc (NASDAQ:<a class="ticker" href="/stock/KOD#NASDAQ">KOD</a>) was changed from Equal-Weight to Underweight. In the fourth quarter, Kodiak Sciences showed an EPS of $0.97, compared to $0.40 from the year-ago quarter. The stock has a 52-week-high of $171.21 and a 52-week-low of $35.49. At the end of the last trading period, Kodiak Sciences closed at $129.01.</li>
<li>Barclays downgraded the previous rating for Editas Medicine Inc (NASDAQ:<a class="ticker" href="/stock/EDIT#NASDAQ">EDIT</a>) from Overweight to Equal-Weight. In the fourth quarter, Editas Medicine showed an EPS of $1.00, compared to $0.74 from the year-ago quarter. At the moment, the stock has a 52-week-high of $99.95 and a 52-week-low of $14.01. Editas Medicine closed at $43.86 at the end of the last trading period.</li>
<li>Barclays downgraded the previous rating for Beam Therapeutics Inc (NASDAQ:<a class="ticker" href="/stock/BEAM#NASDAQ">BEAM</a>) from Overweight to Equal-Weight. For the third quarter, Beam Therapeutics had an EPS of $0.69, compared to year-ago quarter EPS of $3.31. The stock has a 52-week-high of $126.90 and a 52-week-low of $13.00. At the end of the last trading period, Beam Therapeutics closed at $89.13.</li>
<li>Deutsche Bank downgraded the previous rating for ams AG (OTC:<a class="ticker" href="/stock/AMSSY#OTC">AMSSY</a>) from Buy to Hold. At the moment, the stock has a 52-week-high of $14.00 and a 52-week-low of $4.50. ams closed at $11.65 at the end of the last trading period.</li>
<li>According to Bernstein, the prior rating for Pioneer Natural Resources Co (NYSE:<a class="ticker" href="/stock/PXD#NYSE">PXD</a>) was changed from Outperform to Market Perform. In the fourth quarter, Pioneer Natural Resources showed an EPS of $1.07, compared to $2.36 from the year-ago quarter. The stock has a 52-week-high of $153.21 and a 52-week-low of $48.62. At the end of the last trading period, Pioneer Natural Resources closed at $148.57.</li>
<li>According to HC Wainwright &amp; Co., the prior rating for ZIOPHARM Oncology Inc (NASDAQ:<a class="ticker" href="/stock/ZIOP#NASDAQ">ZIOP</a>) was changed from Buy to Neutral. For the fourth quarter, ZIOPHARM Oncology had an EPS of $0.11, compared to year-ago quarter EPS of $0.09. The current stock performance of ZIOPHARM Oncology shows a 52-week-high of $5.95 and a 52-week-low of $1.79. Moreover, at the end of the last trading period, the closing price was at $5.33.</li>
<li>According to Bernstein, the prior rating for Apache Corp (NASDAQ:<a class="ticker" href="/stock/APA#NASDAQ">APA</a>) was changed from Outperform to Market Perform. For the fourth quarter, Apache had an EPS of $0.05, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $26.96 and a 52-week-low of $3.80. Apache closed at $19.73 at the end of the last trading period.</li>
<li>For WSFS Financial Corp (NASDAQ:<a class="ticker" href="/stock/WSFS#NASDAQ">WSFS</a>), Piper Sandler downgraded the previous rating of Overweight to Neutral. In the fourth quarter, WSFS Financial showed an EPS of $1.16, compared to $0.96 from the year-ago quarter. The current stock performance of WSFS Financial shows a 52-week-high of $55.08 and a 52-week-low of $17.84. Moreover, at the end of the last trading period, the closing price was at $53.14.</li>
<li>Wells Fargo downgraded the previous rating for TC Pipelines LP (NYSE:<a class="ticker" href="/stock/TCP#NYSE">TCP</a>) from Overweight to Equal-Weight. TC Pipelines earned $1.01 in the fourth quarter, compared to $0.95 in the year-ago quarter. The stock has a 52-week-high of $41.20 and a 52-week-low of $18.00. At the end of the last trading period, TC Pipelines closed at $29.26.</li>
<li>According to Morgan Stanley, the prior rating for TechnipFMC PLC (NYSE:<a class="ticker" href="/stock/FTI#NYSE">FTI</a>) was changed from Overweight to Equal-Weight. TechnipFMC earned $0.05 in the fourth quarter, compared to $0.03 in the year-ago quarter. The current stock performance of TechnipFMC shows a 52-week-high of $16.17 and a 52-week-low of $4.49. Moreover, at the end of the last trading period, the closing price was at $8.21.</li>
<li>According to RBC Capital, the prior rating for Pactiv Evergreen Inc (NASDAQ:<a class="ticker" href="/stock/PTVE#NASDAQ">PTVE</a>) was changed from Outperform to Sector Perform. Pactiv Evergreen earned $0.10 in the fourth quarter. At the moment, the stock has a 52-week-high of $19.61 and a 52-week-low of $10.40. Pactiv Evergreen closed at $13.98 at the end of the last trading period.</li>
<li>JP Morgan downgraded the previous rating for Agios Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="/stock/AGIO#NASDAQ">AGIO</a>) from Overweight to Neutral. Agios Pharmaceuticals earned $1.41 in the fourth quarter, compared to $1.60 in the year-ago quarter. The current stock performance of Agios Pharmaceuticals shows a 52-week-high of $58.93 and a 52-week-low of $27.77. Moreover, at the end of the last trading period, the closing price was at $47.44.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>
&nbsp;
<h2>Initiations</h2>
<ul>
<li>With an Overweight rating, Morgan Stanley initiated coverage on Sana Biotechnology Inc (NASDAQ:<a class="ticker" href="/stock/SANA#NASDAQ">SANA</a>). The price target seems to have been set at $40.00 for Sana Biotechnology. The current stock performance of Sana Biotechnology shows a 52-week-high of $44.60 and a 52-week-low of $29.99. Moreover, at the end of the last trading period, the closing price was at $30.74.</li>
<li>Morgan Stanley initiated coverage on Boston Beer Co Inc (NYSE:<a class="ticker" href="/stock/SAM#NYSE">SAM</a>) with an Overweight rating. The price target for Boston Beer Co is set to $1400.00. For the fourth quarter, Boston Beer Co had an EPS of $2.64, compared to year-ago quarter EPS of $1.24. The current stock performance of Boston Beer Co shows a 52-week-high of $1236.57 and a 52-week-low of $290.02. Moreover, at the end of the last trading period, the closing price was at $1029.82.</li>
<li>Morgan Stanley initiated coverage on TELUS International (Cda) Inc (NYSE:<a class="ticker" href="/stock/TIXT#NYSE">TIXT</a>) with a Equal-Weight rating. The price target for TELUS International is set to $31.00. In the fourth quarter, TELUS International showed an EPS of $0.09, compared to $0.14 from the year-ago quarter. The stock has a 52-week-high of $33.60 and a 52-week-low of $28.00. At the end of the last trading period, TELUS International closed at $29.12.</li>
<li>With a Buy rating, Stifel initiated coverage on Codexis Inc (NASDAQ:<a class="ticker" href="/stock/CDXS#NASDAQ">CDXS</a>). The price target seems to have been set at $30.00 for Codexis. Codexis earned $0.06 in the fourth quarter, compared to $0.01 in the year-ago quarter. The current stock performance of Codexis shows a 52-week-high of $29.56 and a 52-week-low of $8.43. Moreover, at the end of the last trading period, the closing price was at $22.11.</li>
<li>Credit Suisse initiated coverage on TELUS International (Cda) Inc (NYSE:<a class="ticker" href="/stock/TIXT#NYSE">TIXT</a>) with a Neutral rating. The price target for TELUS International is set to $33.00. TELUS International earned $0.09 in the fourth quarter, compared to $0.14 in the year-ago quarter. The stock has a 52-week-high of $33.60 and a 52-week-low of $28.00. At the end of the last trading period, TELUS International closed at $29.12.</li>
<li>Berenberg initiated coverage on Repare Therapeutics Inc (NASDAQ:<a class="ticker" href="/stock/RPTX#NASDAQ">RPTX</a>) with a Buy rating. The price target for Repare Therapeutics is set to $51.00. In the third quarter, Repare Therapeutics showed an EPS of $0.37, compared to $5.03 from the year-ago quarter. At the moment, the stock has a 52-week-high of $46.44 and a 52-week-low of $21.45. Repare Therapeutics closed at $32.90 at the end of the last trading period.</li>
<li>RBC Capital initiated coverage on Atotech Ltd (NYSE:<a class="ticker" href="/stock/ATC#NYSE">ATC</a>) with an Outperform rating. The price target for Atotech is set to $23.00. At the moment, the stock has a 52-week-high of $20.83 and a 52-week-low of $17.00. Atotech closed at $20.18 at the end of the last trading period.</li>
<li>With a Neutral rating, Credit Suisse initiated coverage on TELUS Corp (NYSE:<a class="ticker" href="/stock/TU#NYSE">TU</a>). The price target seems to have been set at $33.00 for TELUS. For the fourth quarter, TELUS had an EPS of $0.17, compared to year-ago quarter EPS of $0.52. The current stock performance of TELUS shows a 52-week-high of $38.66 and a 52-week-low of $13.54. Moreover, at the end of the last trading period, the closing price was at $20.04.</li>
<li>With an Outperform rating, Credit Suisse initiated coverage on Atotech Ltd (NYSE:<a class="ticker" href="/stock/ATC#NYSE">ATC</a>). The price target seems to have been set at $23.00 for Atotech. At the moment, the stock has a 52-week-high of $20.83 and a 52-week-low of $17.00. Atotech closed at $20.18 at the end of the last trading period.</li>
<li>Credit Suisse initiated coverage on Opendoor Technologies Inc (NASDAQ:<a class="ticker" href="/stock/OPEN#NASDAQ">OPEN</a>) with an Outperform rating. The price target for Opendoor Technologies is set to $37.00. At the moment, the stock has a 52-week-high of $39.24 and a 52-week-low of $21.41. Opendoor Technologies closed at $28.02 at the end of the last trading period.</li>
<li>SVB Leerink initiated coverage on Landos Biopharma Inc (NASDAQ:<a class="ticker" href="/stock/LABP#NASDAQ">LABP</a>) with an Outperform rating. The price target for Landos Biopharma is set to $20.00. At the moment, the stock has a 52-week-high of $15.35 and a 52-week-low of $10.77. Landos Biopharma closed at $13.48 at the end of the last trading period.</li>
<li>With a Buy rating, HC Wainwright &amp; Co. initiated coverage on F-star Therapeutics Inc (NASDAQ:<a class="ticker" href="/stock/FSTX#NASDAQ">FSTX</a>). The price target seems to have been set at $35.00 for F-star Therapeutics. The current stock performance of F-star Therapeutics shows a 52-week-high of $12.20 and a 52-week-low of $6.61. Moreover, at the end of the last trading period, the closing price was at $8.27.</li>
<li>With a Buy rating, HC Wainwright &amp; Co. initiated coverage on Angion Biomedica Corp (NASDAQ:<a class="ticker" href="/stock/ANGN#NASDAQ">ANGN</a>). The price target seems to have been set at $100.00 for Angion Biomedica. The stock has a 52-week-high of $26.30 and a 52-week-low of $16.00. At the end of the last trading period, Angion Biomedica closed at $17.34.</li>
<li>Needham initiated coverage on DZS Inc (NASDAQ:<a class="ticker" href="/stock/DZSI#NASDAQ">DZSI</a>) with a Buy rating. The price target for DZS is set to $23.00. The current stock performance of DZS shows a 52-week-high of $18.90 and a 52-week-low of $2.90. Moreover, at the end of the last trading period, the closing price was at $16.64.</li>
<li>With a Neutral rating, Goldman Sachs initiated coverage on Sana Biotechnology Inc (NASDAQ:<a class="ticker" href="/stock/SANA#NASDAQ">SANA</a>). The price target seems to have been set at $40.00 for Sana Biotechnology. The current stock performance of Sana Biotechnology shows a 52-week-high of $44.60 and a 52-week-low of $29.99. Moreover, at the end of the last trading period, the closing price was at $30.74.</li>
<li>With a Buy rating, Jefferies initiated coverage on Five9 Inc (NASDAQ:<a class="ticker" href="/stock/FIVN#NASDAQ">FIVN</a>). The price target seems to have been set at $220.00 for Five9. In the fourth quarter, Five9 showed an EPS of $0.34, compared to $0.27 from the year-ago quarter. The current stock performance of Five9 shows a 52-week-high of $194.03 and a 52-week-low of $52.51. Moreover, at the end of the last trading period, the closing price was at $185.24.</li>
<li>Piper Sandler initiated coverage on Sensei Biotherapeutics Inc (NASDAQ:<a class="ticker" href="/stock/SNSE#NASDAQ">SNSE</a>) with an Overweight rating. The price target for Sensei Biotherapeutics is set to $25.00. At the moment, the stock has a 52-week-high of $26.50 and a 52-week-low of $15.45. Sensei Biotherapeutics closed at $16.50 at the end of the last trading period.</li>
<li>Goldman Sachs initiated coverage on ON24 Inc (NYSE:<a class="ticker" href="/stock/ONTF#NYSE">ONTF</a>) with a Buy rating. The price target for ON24 is set to $88.00. The stock has a 52-week-high of $81.98 and a 52-week-low of $46.37. At the end of the last trading period, ON24 closed at $56.31.</li>
<li>With a Buy rating, Needham initiated coverage on ON24 Inc (NYSE:<a class="ticker" href="/stock/ONTF#NYSE">ONTF</a>). The price target seems to have been set at $70.00 for ON24. At the moment, the stock has a 52-week-high of $81.98 and a 52-week-low of $46.37. ON24 closed at $56.31 at the end of the last trading period.</li>
<li>KeyBanc initiated coverage on ON24 Inc (NYSE:<a class="ticker" href="/stock/ONTF#NYSE">ONTF</a>) with an Overweight rating. The price target for ON24 is set to $70.00. The stock has a 52-week-high of $81.98 and a 52-week-low of $46.37. At the end of the last trading period, ON24 closed at $56.31.</li>
<li>With an Overweight rating, Piper Sandler initiated coverage on ON24 Inc (NYSE:<a class="ticker" href="/stock/ONTF#NYSE">ONTF</a>). The price target seems to have been set at $70.00 for ON24. At the moment, the stock has a 52-week-high of $81.98 and a 52-week-low of $46.37. ON24 closed at $56.31 at the end of the last trading period.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Upgrades

Downgrades

Initiation

Analyst Ratings

AGIO

AMSSY

ANGN

ARKAY

BCSF

BEAM

CBWBF

CDXS

DZSI

EDIT

FIVN

FSTX

GNHAF

LABP

ONTF

OPEN

PEGRY

PLUG

PPRUY

PTVE

RPTX

SAIL

SANA

SBSNF

SNSE

THNPF

TIXT

TKAYY

VOPKY

WSFS

YNDX

ZIOP

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2021

Goldman Sachs analyst Katherine Tait upgrades Wolters Kluwer (OTC:<a class="ticker" href="/stock/WTKWY#OTC">WTKWY</a>) from Sell to Neutral.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Wolters Kluwer

Wolters Kluwer (WTKWY) Forecast

Wolters Kluwer (OTC:WTKWY) Stock, Quote.Headers.trade-ideas